文献速递产科母胎医学

双胎妊娠中的游离DNA筛查:一种更准确可靠的筛查工具

Cell-free DNA screening in twin pregnancies: A more accurate and reliable screening tool.
PubMed 文献 · Prenat Diagn · 2020-07-28

本研究在一个大型临床实验室对双胎妊娠的cfDNA筛查与诊断结果进行交叉比对,获得422例匹配病例。371例可报告样本对21/18/13三体的总体敏感性98.7%、特异性93.2%,阳性预测值分别为78.7%、84.6%、66.7%。作者认为cfDNA在双胎中筛查主要三体的性能优于传统血清生化筛查。

要点

  • 双胎妊娠cfDNA筛查371例可报告样本对21/18/13三体敏感性98.7%、特异性93.2%。
  • 21、18、13三体阳性预测值分别为78.7%、84.6%、66.7%,研究人群富集非整倍体。
  • 48例(11.5%)初次cfDNA采血样本不可报告,3例羊水细胞分析失败。

核心结论

  • 在具有匹配诊断结果的双胎妊娠队列中,cfDNA筛查性能优于传统血清生化筛查。
  • 不断积累的证据表明cfDNA是双胎妊娠主要三体准确可靠的筛查工具。

研究设计与样本

  • 在一个大型临床实验室对4.5年期间双胎妊娠的产前细胞遗传学和SNP微阵列结果与cfDNA结果进行交叉比对,获得422例匹配病例。
  • 以诊断结果作为真值评估cfDNA筛查在该人群中的性能。

主要发现

  • 422例双胎妊娠中3例羊水细胞分析失败,48例(11.5%)初次cfDNA采血样本不可报告。
  • 371例可报告样本对21/18/13三体的总体敏感性为98.7%,特异性为93.2%。
  • 该研究人群富集非整倍体,21三体、18三体、13三体的阳性预测值分别为78.7%、84.6%、66.7%。

关键数值与推荐

  • 371例可报告样本对21/18/13三体的总体敏感性98.7%、特异性93.2%。
  • 21三体阳性预测值78.7%,18三体84.6%,13三体66.7%。
  • 48例(11.5%)初次cfDNA采血样本不可报告,3例羊水细胞分析失败。

临床怎么用

  • 作者认为cfDNA是双胎妊娠主要三体准确可靠的筛查工具,性能优于传统血清生化筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Outcome data from cell-free DNA (cfDNA) screening in twin gestations are limited. This study adds an appreciable number of confirmed outcomes to the literature, and assesses performance of cfDNA screening in twins over a 4.5-year period at one large clinical laboratory. METHOD: Prenatal cytogenetic and SNP microarray results were cross-referenced with cfDNA results for twin pregnancies, yielding 422 matched cases. Using diagnostic results as truth, performance of cfDNA screening in this population was assessed. RESULTS: Of the 422 twin pregnancies with both cfDNA and diagnostic results, 3 specimens failed amniocyte analysis, and 48 samples (11.5%) were nonreportable from the initial cfDNA draw. Analysis of the 371 reportable samples demonstrated a collective sensitivity of 98.7% and specificity of 93.2% for trisomies 21/18/13. Positive predictive values (PPVs) in this study population, which is enriched for aneuploidy, were 78.7%, 84.6%, and 66.7% for trisomy 21, 18, and 13, respectively. CONCLUSION: CfDNA screening in a cohort of twin pregnancies with matched diagnostic results showed superior performance compared to traditional serum biochemical screening in twins. This study adds to a growing body of evidence suggesting that cfDNA is an accurate and reliable screening tool for the major trisomies in twin pregnancies.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Chibuk J, Rafalko J, Boomer T, et al. Cell-free DNA screening in twin pregnancies: A more accurate and reliable screening tool. Prenat Diagn. 2020. PMID: 32677048. doi:10.1002/pd.5797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。